Spruce Biosciences Inc. (NASDAQ: SPRB)
$0.59
+0.0085 ( +1.47% ) 222.7K
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
Market Data
Open
$0.59
Previous close
$0.58
Volume
222.7K
Market cap
$24.12M
Day range
$0.58 - $0.59
52 week range
$0.50 - $5.95
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 11 | Jun 18, 2024 |
8-k | 8K-related | 11 | Jun 03, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
8-k | 8K-related | 11 | May 24, 2024 |